Literature DB >> 24890805

International Society of Urological Pathology grading and other prognostic factors for renal neoplasia.

Brett Delahunt1, John R Srigley2, Lars Egevad3, Rodolfo Montironi4.   

Abstract

The International Society of Urological Pathology convened an international consensus conference in 2012 to review aspects relating to the prognostic assessment, classification, and diagnosis of adult renal malignancy. The detailed recommendations of the conference are reported.
Copyright © 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Year:  2014        PMID： 24890805     DOI： 10.1016/j.eururo.2014.05.027

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


  10 in total

Review 1.  Long Non-Coding RNAs as Novel Biomarkers in the Clinical Management of Papillary Renal Cell Carcinoma Patients: A Promise or a Pledge?

Authors:  Francesco Trevisani; Matteo Floris; Riccardo Vago; Roberto Minnei; Alessandra Cinque
Journal:  Cells       Date:  2022-05-17       Impact factor: 7.666

2.  Utility of cytokeratin 7, S100A1 and caveolin-1 as immunohistochemical biomarkers to differentiate chromophobe renal cell carcinoma from renal oncocytoma.

Authors:  Keng Lim Ng; Robert J Ellis; Hemamali Samaratunga; Christudas Morais; Glenda C Gobe; Simon T Wood
Journal:  Transl Androl Urol       Date:  2019-05

3.  The prognostic value of galactosylceramide-sulfotransferase (Gal3ST1) in human renal cell carcinoma.

Authors:  Stefan Porubsky; Malin Nientiedt; Maximilian C Kriegmair; Jörn-Helge Heinrich Siemoneit; Roger Sandhoff; Richard Jennemann; Hendrik Borgmann; Timo Gaiser; Cleo-Aron Weis; Philipp Erben; Thomas Hielscher; Zoran V Popovic
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

4.  The ISUP system of staging, grading and classification of renal cell neoplasia.

Authors:  Hemamali Samaratunga; Troy Gianduzzo; Brett Delahunt
Journal:  J Kidney Cancer VHL       Date:  2014-07-20

5.  Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.

Authors:  Pingcuo Laba; Jianfeng Wang; Jin Zhang
Journal:  BMC Cancer       Date:  2018-08-28       Impact factor: 4.430

Review 6.  Prognostic Factors for Localized Clear Cell Renal Cell Carcinoma and Their Application in Adjuvant Therapy.

Authors:  Kalle E Mattila; Paula Vainio; Panu M Jaakkola
Journal:  Cancers (Basel)       Date:  2022-01-04       Impact factor: 6.639

Review 7.  Renal Oncocytoma: The Diagnostic Challenge to Unmask the Double of Renal Cancer.

Authors:  Francesco Trevisani; Matteo Floris; Roberto Minnei; Alessandra Cinque
Journal:  Int J Mol Sci       Date:  2022-02-26       Impact factor: 5.923

Review 8.  Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma.

Authors:  Prashanth Prithviraj; Nuzhat Ahmed; Revati Sharma; Elif Kadife; Mark Myers; George Kannourakis
Journal:  J Exp Clin Cancer Res       Date:  2021-06-07

9.  Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders.

Authors:  A Boilève; M I Carlo; P Barthélémy; S Oudard; D Borchiellini; M H Voss; S George; C Chevreau; J Landman-Parker; M-D Tabone; D D Chism; A Amin; M A Bilen; D Bosse; A Coulomb-L'hermine; Xiaoping Su; T K Choueiri; Nizar M Tannir; Gabriel G Malouf
Journal:  J Immunother Cancer       Date:  2018-12-27       Impact factor: 13.751

Review 10.  Sarcomatoid Dedifferentiation in Renal Cell Carcinoma: From Novel Molecular Insights to New Clinical Opportunities.

Authors:  Véronique Debien; Jonathan Thouvenin; Véronique Lindner; Philippe Barthélémy; Hervé Lang; Ronan Flippot; Gabriel G Malouf
Journal:  Cancers (Basel)       Date:  2019-12-31       Impact factor: 6.639
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.